Author's Answer: Biosimilar Therapy for Inflammatory Bowel Disease

Revista Espanola de Enfermedades Digestivas - Spain
doi 10.4321/s1130-01082014000100015
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Instituto de Salud Carlos III/BNCS/SciELO Espana

Related search

Prostaglandins in Inflammatory Bowel Disease Therapy

Canadian Journal of Gastroenterology
1993English

Pregnancy Outcomes in Women With Inflammatory Bowel Disease Treated With Biosimilar Infliximab

Gastroenterologie a Hepatologie
HepatologyGastroenterology
2018English

Review: Anti-Adhesion Molecule Therapy for Inflammatory Bowel Disease

Therapeutic Advances in Gastroenterology
Gastroenterology
2010English

Rifaximin for Inflammatory Bowel Disease

Digestive Diseases and Sciences
PhysiologyGastroenterology
2010English

Inflammatory Bowel Disease

Annual Review of Immunology
AllergyImmunology
2010English

Inflammatory Bowel Disease

American Journal of Gastroenterology
HepatologyGastroenterology
2007English

"Inflammatory" Bowel Disease.

BMJ
1985English

Inflammatory Bowel Disease

2020English

Inflammatory Bowel Disease

American Journal of Gastroenterology
HepatologyGastroenterology
2006English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy